BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34006586)

  • 1. The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin
    Soldi R; Halder TG; Sampson S; Vankayalapati H; Weston A; Thode T; Bhalla KN; Ng S; Rodriguez Del Villar R; Drenner K; Kaadige MR; Horrigan SK; Batra SK; Salgia R; Sharma S
    J Pharmacol Exp Ther; 2021 Aug; 378(2):77-86. PubMed ID: 34006586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling.
    Choi HK; Choi KC; Yoo JY; Song M; Ko SJ; Kim CH; Ahn JH; Chun KH; Yook JI; Yoon HG
    Mol Cell; 2011 Jul; 43(2):203-16. PubMed ID: 21777810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis.
    Li J; Wang CY
    Nat Cell Biol; 2008 Feb; 10(2):160-9. PubMed ID: 18193033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct ubiquitination of beta-catenin by Siah-1 and regulation by the exchange factor TBL1.
    Dimitrova YN; Li J; Lee YT; Rios-Esteves J; Friedman DB; Choi HJ; Weis WI; Wang CY; Chazin WJ
    J Biol Chem; 2010 Apr; 285(18):13507-16. PubMed ID: 20181957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
    Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
    Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tbl1 promotes Wnt-β-catenin signaling-induced degradation of the Tcf7l1 protein in mouse embryonic stem cells.
    Yu Y; Liu L; Cao J; Huang R; Duan Q; Ye SD
    J Cell Sci; 2024 May; 137(9):. PubMed ID: 38639717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
    Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
    J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TBL1 cleavage alleviates doxorubicin-induced cardiomyocytes death by regulating the Wnt/β-catenin signal pathway.
    Lee SH; Lee J; Oh J; Hwang JT; Lee HJ; Byun HK; Kim HJ; Suh D; Yoon HG; Park SW; Kang SM; Kwon C; Lee SH; Choi HK
    Cardiovasc Res; 2024 May; ():. PubMed ID: 38722811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.
    Youssef Y; Karkhanis V; Chan WK; Jeney F; Canella A; Zhang X; Sloan S; Prouty A; Helmig-Mason J; Tsyba L; Hanel W; Zheng X; Zhang P; Chung JH; Lucas DM; Kauffman Z; Larkin K; Strohecker AM; Ozer HG; Lapalombella R; Zhou H; Xu-Monette ZY; Young KH; Han R; Nurmemmedov E; Nuovo G; Maddocks K; Byrd JC; Baiocchi RA; Alinari L
    Haematologica; 2021 Nov; 106(11):2927-2939. PubMed ID: 33054136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.
    Zhang J; Tsoi H; Li X; Wang H; Gao J; Wang K; Go MY; Ng SC; Chan FK; Sung JJ; Yu J
    Gut; 2016 Sep; 65(9):1482-93. PubMed ID: 26071132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modelling suggests a differential impact of β-transducin repeat-containing protein paralogues on Wnt/β-catenin signalling dynamics.
    Benary U; Kofahl B; Hecht A; Wolf J
    FEBS J; 2015 Mar; 282(6):1080-96. PubMed ID: 25601154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.
    Wong MM; Guo C; Zhang J
    Am J Clin Exp Urol; 2014; 2(3):169-87. PubMed ID: 25374920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth.
    Park SY; Na Y; Lee MH; Seo JS; Lee YH; Choi KC; Choi HK; Yoon HG
    Oncotarget; 2016 Jul; 7(27):41110-41122. PubMed ID: 27129164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.
    Fiskus W; Sharma S; Saha S; Shah B; Devaraj SG; Sun B; Horrigan S; Leveque C; Zu Y; Iyer S; Bhalla KN
    Leukemia; 2015 Jun; 29(6):1267-78. PubMed ID: 25482131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response.
    Mir R; Sharma A; Pradhan SJ; Galande S
    Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30181396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer.
    Wang Z; Li Z; Wu Q; Li C; Li J; Zhang Y; Wang C; Sun S; Sun S
    Cell Death Dis; 2020 Aug; 11(8):642. PubMed ID: 32811806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
    Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
    Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation.
    Park S; Gwak J; Cho M; Song T; Won J; Kim DE; Shin JG; Oh S
    Mol Pharmacol; 2006 Sep; 70(3):960-6. PubMed ID: 16735606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
    Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
    PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders.
    García-Ibarbia C; Delgado-Calle J; Casafont I; Velasco J; Arozamena J; Pérez-Núñez MI; Alonso MA; Berciano MT; Ortiz F; Pérez-Castrillón JL; Fernández AF; Fraga MF; Zarrabeitia MT; Riancho JA
    Gene; 2013 Dec; 532(2):165-72. PubMed ID: 24096177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.